Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.
A Colorado woman filed a lawsuit in the federal Taxotere permanent hair loss litigation, alleging the cancer treatment caused severe permanent hair loss problems.
The plaintiff, Cynthia C., filed her Taxotere permanent hair loss litigation against Sanofi S.A. at the end of March. According to the Taxotere permanent hair loss litigation, Cynthia began treatment with Taxotere in September 2014, and continued these rounds of treatment through December 2014.
The Taxotere permanent hair loss litigation was filed on multiple counts, including failure to warn, misrepresentation, negligence, fraudulent misrepresentation and concealment, fraud and deceit, and breach of express warranty, among several others.
Background of Taxotere
Taxotere, otherwise known as docetaxel, is manufactured and sold by Sanofi. Taxotere is one of the most popular breast cancer treatment drugs, and is also used for other cancer treatments, including lung cancer. Taxotere was approved by the U.S. Food and Drug Administration (FDA) in 1996. Since its introduction to the market, Taxotere has grown increasingly more popular across the country.
Taxotere fights cancer by preventing cancer cells from growing, which prevents the cancer from its ability to quickly spread. However, the same function that prevents the rapid growth of cancer cells may also prevent a patient’s hair from growing back after chemotherapy.
While cancer patients generally expect that they may lose their hair while undergoing chemotherapy cancer treatment, they also expect that their hair will grow back. However, many cancer patients have discovered after cancer treatment with particular drugs, including Taxotere, their hair will either not grow back or grows back with great difficulty.
Permanent Hair Loss Lawsuits
According to this Taxotere permanent hair loss lawsuit and others like it, Sanofi either knew or should have known that Taxotere was linked with the risk of permanent hair loss.
However, the plaintiff alleges that the company not only failed to adequately warn about this risk, but even actively concealed this risk, instead promoting the drug as both safe and effective. Indeed, patients claim that Sanofi has been aware of reports and studies linking Taxotere to permanent hair loss after chemotherapy since as far back as its approval in 1996.
How to Join Taxotere Permanent Hair Loss Litigation
If you or someone you love has suffered from serious side effects of Taxotere including alopecia, or permanent hair loss after cancer treatment, you may be able to gain some kind of financial compensation by joining Taxotere permanent hair loss litigation.
Filing a Taxotere lawsuit cannot take away the pain and suffering a cancer patient endures, or take away the effects of permanent hair loss, but it can help compensate for the financial expenses incurred by cancer treatment bills or even lost wages.
The Taxotere Permanent Hair Loss Litigation is Case No. 2:17-cv-03669-KDE-MBN, in the U.S. District Court for the Eastern District of Louisiana.
Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Taxotere class action lawsuit is best for you. [In general, Taxotere lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.
ATTORNEY ADVERTISING
Top Class Actions is a Proud Member of the American Bar Association
LEGAL INFORMATION IS NOT LEGAL ADVICE
Top Class Actions Legal Statement
©2008 – 2024 Top Class Actions® LLC
Various Trademarks held by their respective owners
This website is not intended for viewing or usage by European Union citizens.
Get Help – It’s Free
Join a Free Taxotere Class Action Lawsuit Investigation
If you received intravenous chemotherapy treatment for breast cancer and were told that your hair would grow back but it never did, you may have a legal claim. Permanent hair loss is defined as a minimum of 6 months after the Taxotere chemotherapy treatment ended, and there is still no new hair growth. Join this free Taxotere class action lawsuit investigation now!
An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.
Please Note:Â If you want to participate in this investigation, it is imperative that you reply to the law firm if they call or email you. Failing to do so may result in you not getting signed up as a client, if you qualify, or getting you dropped as a client.
Oops! We could not locate your form.